How Much Did Beyond Air Raise?
Funding & Key Investors

Beyond Air has secured $122.6M in total capital, with its most recent financing round bringing in $32M. This major enterprise-level funding and strategic investment signal a significant phase of growth for the medical device and biopharmaceutical company.

What is Beyond Air?

Beyond Air
ManufacturingMedical Devices & EquipmentPharmaceuticals

Founded in 2011 and headquartered in Garden City, New York, Beyond Air is a medical device and biopharmaceutical company focused on leveraging nitric oxide (NO) for therapeutic purposes. Its proprietary LungFit system generates NO from ambient air, delivering precise amounts to the lungs for the potential treatment of various pulmonary diseases. The company's innovative approach positions it within the rapidly evolving respiratory care market, aiming to address unmet clinical needs through advanced NO-based therapies.

How much funding has Beyond Air raised?

Beyond Air has raised a total of $122.6M across 4 funding rounds:

2021

Other Financing Round

$30M

2023

Debt

$40M

2024

Share Placement

$20.6M

2025

Debt

$32M

Other Financing Round (2021): $30M, investors not publicly disclosed

Debt (2023): $40M led by Avenue Capital Group

Share Placement (2024): $20.6M, investors not publicly disclosed

Debt (2025): $32M featuring Streeterville Capital

Key Investors in Beyond Air

Streeterville Capital

Streeterville Capital LLC is a venture capital and private equity firm known for its investments in various companies. Its participation in this funding round suggests a strategic interest in Beyond Air's growth trajectory and market potential.

Avenue Capital Group

Avenue Capital Group is a multinational investment firm specializing in distressed securities and private equity. Their involvement indicates confidence in Beyond Air's financial strategy and long-term viability.

What's next for Beyond Air?

The substantial enterprise-level funding and recent strategic investment indicate Beyond Air is poised for significant scaling and further development of its NO Generator and Delivery System. This capital infusion is likely to accelerate clinical trials, expand manufacturing capabilities, and support market penetration efforts. The company's focus on harnessing nitric oxide for pulmonary diseases suggests a strategic push to establish leadership in this specialized therapeutic area, potentially leading to new product launches and broader adoption of its technology.

See full Beyond Air company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingMedical Devices & Equipment
Building MaterialsManufacturingFurniture
Food & BeverageManufacturingGrocery RetailRetail
Building MaterialsManufacturingConstruction ManagementConstruction

Frequently Asked Questions Regarding Beyond Air Financial Insights

What are the most recent funding rounds that Beyond Air has completed, and what were the funding rounds?
Beyond Air has recently completed 3 funding rounds: Debt on Nov 4, 2025, Share Placement on Sep 26, 2024, Debt on Jun 15, 2023.
What is the total amount of funding Beyond Air has raised to date?
Beyond Air has raised a total of $122.6M in funding to date.
How many funding rounds has Beyond Air completed?
Beyond Air has completed 3 funding rounds.
How much funding did Beyond Air raise in its most recent funding round?
Beyond Air raised $32M in its most recent funding round.
Who are the lead investors in Beyond Air's latest funding round?
The lead investor in Beyond Air's latest funding round was Streeterville Capital. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Beyond Air's history?
The largest funding round in Beyond Air's history was $40M.
See more information about Beyond Air